July 16, 2024 – Page 8 – Goldea Capital

Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program

Written by Customer Service on July 16, 2024. Posted in Public Companies.

Becomes the second hospital in Austria to utilize Senhance RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement to lease and utilize a Senhance® Surgical System. LKH-Universitätsklinikum Graz is a renowned healthcare institution known for its expertise in minimally invasive pediatric and adolescent surgery. This hospital will be the 7th pediatric-focused site to utilize the state-of-the-art Senhance Surgical System using 3mm and 5mm instruments for a variety of minimally invasive procedures. “We are thrilled to collaborate with LKH-Universitätsklinikum Graz for the initiation of our Senhance Surgical...

Intermediate Capital Group plc: Results of 2024 Annual General Meeting

Written by Customer Service on July 16, 2024. Posted in Public Companies.

Intermediate Capital Group PLC (the “Company”) 16 July 2024 Results of 2024 Annual General Meeting The Company announces that at its Annual General Meeting (“AGM”) held this morning, all resolutions proposed were duly passed by the requisite majority the details of which are set out in the table below: RESOLUTION DESCRIPTION VOTES FOR % FOR VOTES AGAINST % AGAINST VOTES TOTAL % of ISC VOTED VOTES WITHHELD RES 1 FINANCIAL STATEMENTS 213,045,731 99.85% 315,436 0.15% 213,361,167 73.41% 1,627,674 RES 2 REMUNERATION REPORT 208,944,142 97.19% 6,030,540 2.81% 214,974,682 73.97% 14,159 RES 3 RE-APPOINT AUDITOR 210,957,557 98.13% 4,028,503 1.87% 214,986,060 73.97% 2,781 RES 4 AUDITORS REMUNERATION 214,859,010 99.94% 128,175 0.06% 214,987,185 73.97% 1,656 RES 5 FINAL DIVIDEND 214,975,783 99.99% 11,742 0.01% 214,987,525 73.97% 1,316 RES...

DT Midstream to Announce Second Quarter 2024 Financial Results, Schedules Earnings Call

Written by Customer Service on July 16, 2024. Posted in Public Companies.

DETROIT, July 16, 2024 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) plans to announce second quarter 2024 financial results before the market opens on Tuesday, July 30, 2024. DT Midstream has scheduled a conference call to discuss results for 9:00 a.m. ET (8:00 a.m. CT) the same day. Investors, the news media and the public may listen to a live internet broadcast of the call at this link. The participant toll-free telephone dial-in number in the U.S. and Canada is 888.596.4144, and the toll number is 646.968.2525; the passcode is 4749988. International access numbers are available here. The webcast will be archived on the DT Midstream website at investor.dtmidstream.com. About DT Midstream DT Midstream (NYSE: DTM) is an owner, operator and developer of natural gas interstate and intrastate pipelines, storage and gathering...

Kronos Advanced Technologies Inc. Warns Consumers to Use Only FDA-Cleared Air Purifiers at Home and Office

Written by Customer Service on July 16, 2024. Posted in Public Companies.

Kronos Advanced Technologies Inc. Warns Consumers to Use Only FDA-Cleared Air Purifiers at Home and Office Los Angeles, CA , July 16, 2024 (GLOBE NEWSWIRE) — Los Angeles, CA July 16, 2024 (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), an innovation-driven product development company and creator of the patented Kronos® CORE air disinfection technology inside its advanced smart air purification devices a leading innovator in air purification technology, issues an urgent consumer warning to use only FDA-cleared air purifiers in residential and office environments. This advisory comes in response to growing concerns about the safety and effectiveness of non-FDA-cleared air purification products currently on the market. Air quality has become a critical...

SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss

Written by Customer Service on July 16, 2024. Posted in Public Companies.

TEL AVIV, Israel, July 16, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that an additional patent application with the United States Patent and Trademark Office (“USPTO”) was submitted as part of its ongoing collaboration with Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems and invented with Professor Joseph Tam from the Hebrew University’s technology transfer company, Yissum. The patent application is for the novel proprietary...

Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss

Written by Customer Service on July 16, 2024. Posted in Public Companies.

Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that it has submitted an additional patent application with the United States Patent and Trademark Office (“USPTO”), as part of its ongoing collaborations with SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, and with invented with Prof. Joseph Tam from the Hebrew University’s technology transfer company, Yissum. The patent application refers to the novel proprietary composition of Clearmind’s...

Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President

Written by Customer Service on July 16, 2024. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced changes to its leadership team. Nadir Mahmood, Ph.D., will join Nkarta as President this month, sharing executive leadership responsibilities with Paul J. Hastings, who continues in his role as Chief Executive Officer. Additionally, Nkarta has broadened the role of David R. Shook, M.D., to Chief Medical Officer, Head of Research & Development. Drs. Mahmood and Shook will both report to Mr. Hastings. “This new leadership structure enables Nkarta to meet this transformative moment for cell therapy as we embark on groundbreaking clinical trials and expand our footprint in multiple autoimmune disease settings. These executive changes...

Huize Holding Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Written by Customer Service on July 16, 2024. Posted in Public Companies.

SHENZHEN, China, July 16, 2024 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize” or the “Company”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in China, today announced that it has received a notification letter (the “Compliance Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market Inc. (“Nasdaq”) dated July 15, 2024, informing the Company that it has regained compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). As previously announced, the Company was notified by Nasdaq on January 5, 2024 that the Company was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company’s American depositary shares (“ADSs”)...

K92 Mining Schedules 2024 Second Quarter Financial Results Conference Call

Written by Customer Service on July 16, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) announces that it will release its 2024 second quarter financial results after the North American trading markets close on Tuesday, August 13, 2024. Conference Call and Webcast to Present Results K92 will host a conference call and webcast to present the 2024 second quarter financial results at 5:30 pm (EDT) on Tuesday, August 13, 2024. Listeners may access the conference call by dialing toll-free to 1-844-763-8274 within North America or +1-647-484-8814 from international locations. The conference call will also be broadcast live (webcast) and may be accessed via the following link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=KeTO9ljU About K92 K92 Mining Inc. is engaged in the production...

RadNet, Inc. Announces Date of its Second Quarter 2024 Financial Results Conference Call

Written by Customer Service on July 16, 2024. Posted in Public Companies.

LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its second quarter 2024 financial results on Thursday, August 8, 2024 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet’s conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1680804&tp_key=197206db18. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers,...

Day: July 16, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice